CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

Efficient reprogramming of fibroblasts into iPSCs using mRNA technology

Efficient reprogramming of fibroblasts into iPSCs using mRNA technology

Sebastian Diecke, Hannah Johannsen, Parivash Nouri
05 December 2023
Watch
 Pioneering the development of point-of-care CAR T cell therapy manufacturing in Canada: experience from the CLIC-01 CD19 CAR T clinical trial

Pioneering the development of point-of-care CAR T cell therapy manufacturing in Canada: experience from the CLIC-01 CD19 CAR T clinical trial

Natasha Kekre
14 November 2023
Watch
 Cell sorting for enrichment of neuronal subpopulations – new perspectives for clinical research

Cell sorting for enrichment of neuronal subpopulations – new perspectives for clinical research

Thomas Andreska, Elisa Nent, Chengjun Jin
05 October 2023
Watch
 How patient focus drives clinical trial results: the intersection of sponsor, CRO, site, and patient

How patient focus drives clinical trial results: the intersection of sponsor, CRO, site, and patient

K Kane, K Nealon, B Bratrude et al
07 September 2023
Watch
 Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Sophia Lollies, Ian Johnston
31 August 2023
Watch
 Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle
26 July 2023
Watch
 Overcoming challenges in scaled manufacturing of iPSC-derived cells

Overcoming challenges in scaled manufacturing of iPSC-derived cells

A Steinbach, D Mann, M Diakatou et al
06 July 2023
Watch
 A shortcut through process development for CAR-T cell manufacturing

A shortcut through process development for CAR-T cell manufacturing

Marko Gogala
27 June 2023
Watch
 Optimizing the cell therapy patient journey through integrated CRO/CDMO partnership

Optimizing the cell therapy patient journey through integrated CRO/CDMO partnership

Panteli Theocharous, Rupa Pike
06 June 2023
Watch
 Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Stephan Wilmes
23 May 2023
Watch
 Manufacturing and testing a clinical-grade AAV vector: from concept to clinic

Manufacturing and testing a clinical-grade AAV vector: from concept to clinic

Chris Edwards, James Cody
04 May 2023
Watch
 Next-generation CRISPR mRNA-LNPs and scale up manufacturing for CAR T cells

Next-generation CRISPR mRNA-LNPs and scale up manufacturing for CAR T cells

Reka Geczy, Bernice Thommandru
23 March 2023
Watch
 Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F Boj, Andrea Bisso
02 March 2023
Watch
 Understanding donor characteristics to improve allogeneic cell therapy outcomes for all

Understanding donor characteristics to improve allogeneic cell therapy outcomes for all

Abeer Madbouly, Martin Maiers, Stephen Sullivan
28 February 2023
Watch
 Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Sung Lee, Deepak Kumar
08 December 2022
Watch
 Navigating scalability and consistency in the allogeneic supply chain

Navigating scalability and consistency in the allogeneic supply chain

Anne Dircks, Dean Lee MD PhD
01 November 2022
Watch
 Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

Michael Krainock, Alan Tan, John Simmons
19 October 2022
Watch
 Transient expression of mRNA lipid nanoparticle-based chimeric antigen receptors for safe immunotherapy

Transient expression of mRNA lipid nanoparticle-based chimeric antigen receptors for safe immunotherapy

Sandy Tretbar
06 July 2022
Watch
 Accelerating cell therapy discovery & development with non-viral gene engineering

Accelerating cell therapy discovery & development with non-viral gene engineering

David Hermanson, Xiaobai Patrinostro, Scott Silaika
16 June 2022
Watch
 Discovery to manufacturing: A continuum

Discovery to manufacturing: A continuum

Audrey Chang, Tony Hitchcock, Brian Fry
05 April 2022
Watch
 Cell and gene therapy matures: Streamlining and smoothing the path to commercialization

Cell and gene therapy matures: Streamlining and smoothing the path to commercialization

Matt Hewitt PhD
11 January 2022
Watch